Perihal Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Ibu pejabat251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Ditubuhkan2018
StatusAktif
Paten1 paten
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Ulasan
Belum ada ulasan. Pernah bekerja dengan Assertio Therapeutics, Inc.? Jadilah yang pertama berkongsi pengalaman anda.
Maklumat undang-undang
| Nama sah | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Lihat di GLEIF ↗ |
| Alamat berdaftar | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Status | Aktif |
Sumber: GLEIF · dikemas kini 16 Okt 2026
Hubungan & pautan
Lokasi
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Adakah ini syarikat anda?
Tuntut halaman ini secara percuma untuk menambah logo, produk, foto dan kerja anda, serta menjawab ulasan.
Tuntut halaman iniSertai Heelky untuk berhubung, menggaji dan berkembang
Cipta akaun percuma untuk menghantar mesej, memohon kerja dan menyiarkan misi.
Sertai sekarang — percuma